Nanomedicine as an emerging approach against intracellular pathogens

References

• AkhtarJShuklaDViral entry mechanisms: cellular and viral mediators of herpes simplex virus entryFEBS J200927677287736
   Web of Science ®Google Scholar
• WilsonSSFakioglyEHeroldBCNovel approaches in fighting herpes simplex virus infectionsExpert Rev Anti Infect Ther2009755956819485796
   PubMed Web of Science ®Google Scholar
• AlterMJEpidemiology of hepatitis c virus infectionWorld J Gastroenterol2007132436244117552026
   PubMed Web of Science ®Google Scholar
• SharmaSDHepatitis c virus: molecular biology and current therapeutic optionsIndian J Med Res2010131173420167971
   PubMed Web of Science ®Google Scholar
• EmpeyKMStokes PeeblesJRKollsJKPharmacological advances in the treatment and prevention of respiratory syncytial virusClin Infect Dis2010501258126720235830
   PubMed Web of Science ®Google Scholar
• WelliverRCPharmacotherapy of respiratory syncytial virusCurr Opin Pharmacol20101028929320493773
   PubMed Web of Science ®Google Scholar
• ChatterjeeKHost genetic factors in susceptibility to HIV and progression to AIDSJ Genet20108910911620505255
   PubMed Web of Science ®Google Scholar
• EsteJACihlarTCurrent status and challenges of antiretroviral research and therapyAntiviral Res201085253320018390
   PubMed Web of Science ®Google Scholar
• LoBuePSEnarsonDAThoenTCTuberculosis in humans and its epidemiology, diagnosis and treatment in the United StatesInt J Tuberc Lung Dis20101411261232
   Web of Science ®Google Scholar
• FlynnJLChanJImmunology of tuberculosisAnnu Rev Immunol2001199312911244032
   PubMed Web of Science ®Google Scholar
• LahiriALahiriAIyerNDasPChakravorttyDVisiting the cell biology of salmonella infectionMicrobes Infect20101280981820538070
   PubMed Web of Science ®Google Scholar
• WatsonKGHoldenDWDynamics of growth and dissemination of Salmonella in vivoCell Microbiol2010121389139720731667
   PubMed Web of Science ®Google Scholar
• FrancoMPMulderMGilmanRHSmitsHLHuman brucellosisLancet Infect Dis2007777578618045560
   PubMed Web of Science ®Google Scholar
• GamazoCLecarozMCPriorSVitasAICampaneroMAIracheJMChemical and biological factors in the control of Brucella and brucellosisCurr Drug Deliv2006335936517076637
   PubMedGoogle Scholar
• RoopRMBellairBHValderasMWCardelliJAAdaptation of the brucellae to their intracellular nicheMol Microbiol20045262163015101970
   PubMed Web of Science ®Google Scholar
• TheirotJAThe cell biology of infection by intracellular bacterial pathogensAnnu Rev cell Dev Biol1995112132398689557
   PubMed Web of Science ®Google Scholar
• Lopez-MartinezRCandidosis, a new challengeClin Dermatol20102817818420347660
   PubMed Web of Science ®Google Scholar
• BalloyVChignardMThe innate immune response to Aspergillus fumigatisMicrobes Infect20091191992719615460
   PubMed Web of Science ®Google Scholar
• GomezMAOlivierMProteases and phosphatases during Leishmania- macrophage interaction: paving the road for pathogenesisVirulence2010131431821178462
   PubMed Web of Science ®Google Scholar
• GotoHAngeloJLindosoLCurrent diagnosis and treatment of cutaneous and mucocutaneous leishmaniasisExpert Rev Anti Infect Ther2010841943320377337
   PubMed Web of Science ®Google Scholar
• SadanandSMalaria: an evaluation of the current state of research on pathogenesis and antimalarial drugsYale J Biol Med20108318519121165337
   PubMedGoogle Scholar
• BrionesEColinoCILanaoJMDelivery systems to increase the selectivity of antibiotics in phagocytic cellsJ Control Release200812521022718077047
   PubMed Web of Science ®Google Scholar
• ChiangCYSchaafHSManagement of drug-resistant tuberculosisInt J Tuberc Lung Dis20101467268220487603
   PubMed Web of Science ®Google Scholar
• NguyenHMGraberCJLimitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answerJ Antimicrob Chemother200965243619861337
   PubMed Web of Science ®Google Scholar
• WoodfordNLivermoreDMInfections caused by gram-positive bacteria: a review of the global challengeJ Infect200959Suppl 1S41619766888
   PubMed Web of Science ®Google Scholar
• FinchRBacterial resistance-the clinical challengeClin Microbiol Infect20028Suppl 3213212519346
   PubMed Web of Science ®Google Scholar
• HawkeyPMJonesAmThe changing epidemiology of resistanceJ Antimicrob Chemother200964Suppl 1310
   PubMed Web of Science ®Google Scholar
• GoossensHAntibiotic consumption and link to resistanceClin Microbiol Infect200915Suppl 3121519366364
   PubMed Web of Science ®Google Scholar
• Margeridon-ThermetSShaferRWComparison of the mechanisms of drug resistance among HIV, hepatitis B and hepatitis C virusesViruses201022696273921243082
   PubMed Web of Science ®Google Scholar
• KaufmanSHEFuture vaccination strategies against tuberculosis: thinking outside the boxImmunity20103356757721029966
   PubMed Web of Science ®Google Scholar
• LallooUGAmbaramANew antituberculosis drugs in developmentCurr HIV/AIDS Rep2010714315120559756
   PubMedGoogle Scholar
• Signs and symptoms of TB diseaseAtlanta, GACenters for Disease Control and Prevention2010 Available from: http://www.cdc.gov/tb/topic/basics/signsandsymptoms.htmAccessed November 10, 2011
   Google Scholar
• Tuberculosis: general informationAtlanta, GACenters for Disease Control and Prevention2010 Available from: http://www.cdc.gov/tb/publications/factsheets/general/tb.htmAccessed November 10, 2011
   Google Scholar
• AhmadSPathogenesis, immunity and diagnosis of latent Mycobacterium tuberculosis infectionClin Dev Immunol2011201181494321234341
   PubMedGoogle Scholar
• LinPLFlynnJLUnderstanding latent tuberculosis: a moving targetJ Immunol2010185152220562268
   PubMed Web of Science ®Google Scholar
• KumarDRaoKVSRegulation between survival, persistence, and elimination of intracellular mycobacteria: a nested equilibrium of delicate balancesMicrobes Infect20111312113320971210
   PubMed Web of Science ®Google Scholar
• GasparMCruzAFragaACastroACruzMEMPedrosaJDevelopments on drug delivery systems for the treatment of mycobacterial infectionsCurr Top Med Chem2008857959118473884
   PubMed Web of Science ®Google Scholar
• GarnerPSmithHMunroSVolminkJPromoting adherence to tuberculosis treatmentBull World Health Organ20078540440617639229
   PubMed Web of Science ®Google Scholar
• AsplerAMenziesDOxladeOBandaJMwengeLGodfrey-FaussettPCost of tuberculosis diagnosis and treatment from the patient perspective in Lusaka, ZambiaInt J Tuberc Lung Dis20081292893518647453
   PubMed Web of Science ®Google Scholar
• OnoshitaTShimizuYYamayaNMiyazakiMYokoyamaMFujiwaraNThe behavior of PLGA microspheres containing rifampicin in alveolar macrophagesColloids Surf B Biointerfaces20107615115719954935
   PubMed Web of Science ®Google Scholar
• Global summary of the AIDS epidemic2009Geneva, SwitzerlandWorld Health Organization2009 Available from: http://www.who.int/hiv/data/2009_global_summary.pngAccessed November 10, 2011
   Google Scholar
• WohlDADeconstructing most recent antiretroviral recommendationsCurr HIV/AIDS Rep20107778420425561
   PubMedGoogle Scholar
• ClercqEDHighlights in the discovery of antiviral drugs: a personal retrospectiveJ Med Chem2010531438145019860424
   PubMed Web of Science ®Google Scholar
• ZolopaARThe evolution of HIV treatment guidelines: current state-of- the-art of ARTAntiviral Res20108524124419883695
   PubMed Web of Science ®Google Scholar
• GuptaUJainNKNon-polymeric nano-carriers in HIV/AIDS drug delivery and targetingAdv Drug Deliv Rev20106247849019913579
   PubMed Web of Science ®Google Scholar
• WatersLNelsonMWhy do patients fail HIV therapyInt J Clin Pract20076198399017504360
   PubMed Web of Science ®Google Scholar
• LavanchyDEvolving epidemiology of hepatitis C virusClin Microbiol Infect20111710711521091831
   PubMed Web of Science ®Google Scholar
• CastelloGScalaSPalmieriGCurleySAIzzoFHCV-related hepatocellular carcinoma: from chronic inflammation to cancerClin Immunol201013023725019910258
   PubMed Web of Science ®Google Scholar
• YuCIChiangBLA new insight into hepatitis C vaccine developmentJ Biomed Biotechnol2010201054828020625493
   PubMedGoogle Scholar
• ZhangXLJezaVTPanQSalmonella typhi: from a human pathogen to a vaccine vectorCell Mol Immunol20085919718445338
   PubMed Web of Science ®Google Scholar
• Typhoid fever: general informationAtlanta, GACenters for Disease Control and Prevention2010 Available from: http://www.cdc.gov/nczved/divisions/dfbmd/diseases/typhoid_feverAccessed November 10, 2011
   Google Scholar
• TrebichavskyISplichalISplichalovaAInnate immune response in the gut against Salmonella-reviewFolia Microbiol20105529530020526845
   PubMed Web of Science ®Google Scholar
• BuchmeierNAHeffronFInhibition of macrophage phagosome-lysosome fusion by Salmonella typhimuriumInfect Immun199159223222382050395
   PubMed Web of Science ®Google Scholar
• GuzmanCABorsutzkySGiot-WentMMetcalfeICPearmanJCollioudAVaccines against typhoid feverVaccine2006243804381116278037
   PubMed Web of Science ®Google Scholar
• ThaverDZaidiAKMCritchleyJAzmatullahAMadniSAButtaZAA comparison of fluoroquinolones versus other antibiotics for treating enteric fever: meta-analysisBMJ2009338b186519493939
   PubMed Web of Science ®Google Scholar
• LawlorCKellyCO’LearySO’SullivanMPGallagherPJKeaneJCellular targeting and trafficking of drug delivery systems for the prevention and treatment of MTbTuberculosis201091939721237714
   PubMed Web of Science ®Google Scholar
• Al-KhodorSKwalkYATriggering Ras signaling by intracellular Francisella tularensis through recruitment of PKC-alpha and beta-I to the SOS2/GrB2 complex is essential for bacterial proliferation in the cytosolCell Microbiol2010121604162120618341
   PubMed Web of Science ®Google Scholar
• CollinsCABrownEJCytosol as a battle ground: ubiquitination as a weapon for both host and pathogenTrends Cell Biol20102020521320129784
   PubMed Web of Science ®Google Scholar
• D’OrsognaMRChouTOptimal cytoplasmic transport in viral infectionsPLoS One2009481658172
   Web of Science ®Google Scholar
• CalderJMStowECStowNDOn the cellular localization of the components of the herpes simplex virus type. 1 helicase-primase complex and the viral origin-binding proteinJ Gen Virol1992735315381312116
   PubMed Web of Science ®Google Scholar
• HeuerDLipinskiARMachuyNKarlasAWehrensASiedlerFChlamydia causes fragementation of the golgi compartment to ensure reproductionNature200945773173519060882
   PubMed Web of Science ®Google Scholar
• TilneyLGHarbOSConnellyPSRobinsonCGRoyCRHow the parasitic bacterium Legionella pneumophilia modifies its phagosome and transforms it into rough ER: implications for conversion of plasma membrane to the ER membraneJ Cell Sci20011144637465011792828
   PubMed Web of Science ®Google Scholar
• CelliJChastellierCFranchiniDMPizaroo-CerdaJMorenoEGorvelJPBrucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulumJ Exp Med200319854555612925673
   PubMed Web of Science ®Google Scholar
• RoyCRSalcedoSPGorvelJPEPathogen-endoplasmic reticulum interactions: in through the out doorNat Rev immunol2006613614716491138
   PubMed Web of Science ®Google Scholar
• MoradpourDGosertREggerDPeninFBlumHEBienzKMembrane association of hepatitis C virus nonstructural proteins and identification of the membrane alteration that harbors the viral replication complexAntiviral Res20036010310914638405
   PubMed Web of Science ®Google Scholar
• SinaiAPWebsterPJoinerKAAssociation of host cell endoplasmic reticulum and mitochondria with the Toxoplasma gondii parasitophorous vacuole membrane: a high affinity interactionJ Cell Sci1997110211721289378762
   PubMed Web of Science ®Google Scholar
• SandegrenLAnderssonDIBacterial gene amplification: implications for the evolution of antibiotic resistanceNat Rev Microbiol2009757858819609259
   PubMed Web of Science ®Google Scholar
• SendiPProctorRAStaphylococcus aureus as an intracellular pathogen: the role of small colony variantsTrends Microbiol200917545819162480
   PubMed Web of Science ®Google Scholar
• GarzoniCKellyWLStaphylococcus aureus: new evidence for intracellular persistenceTrends Microbiol200917596519208480
   PubMed Web of Science ®Google Scholar
• HudsonMCRampWKNicholsonNCWilliamsASNousiainenMTInternalization of Staphylococcus aureus by cultured osteoblastsMicrob Pathog1995194094198852281
   PubMed Web of Science ®Google Scholar
• JevonMGuoCMaBCMordanNNairSPHarrisMMechanisms of internalization of Staphylococcus aureus by cultured human osteoblastsInfect Immun1999672677268110225942
   PubMed Web of Science ®Google Scholar
• SinhaBFraunholzMStaphylococcus aureus host cell invasion and post-invasion eventsInt J Med Microbiol201030017017519781990
   PubMed Web of Science ®Google Scholar
• EllingtonJHarrisMWebbLSmithBSmithTTanKIntracellular Staphylococcus aureus: a mechanism for the indolence of osteomyelitisJ Bone Joint Surg Br20038591892112931819
   PubMedGoogle Scholar
• FreitasRAWhat is nanomedicineNanomedicine200512917292052
   PubMed Web of Science ®Google Scholar
• Seale-GoldsmithMMLearyJFNanobiosystemsNanomed Nanobiotechnol20091553567
   Web of Science ®Google Scholar
• AsteteCESavliovCMSynthesis and characterization of PLGA nanoparticlesJ Biomater Sci Polymer Edn200617247289
   PubMed Web of Science ®Google Scholar
• AvgoutstakisKPegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug deliveryCurr Drug Deliv2004132133316305394
   PubMedGoogle Scholar
• LuJMWangXMarin-MullerCWangHLinPHYaoQCurrent advances in research and clinical application of PLGA–based nanotechnologyExpert Rev Mol Diagn2009932534119435455
   PubMed Web of Science ®Google Scholar
• PanyamJZhouWZPrabhaSSahooSKLabhasetwarVRapid endolysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene deliveryFASEB J2002161217122612153989
   PubMed Web of Science ®Google Scholar
• QaddoumiMGUedaHYangJDavdaJLabhasetwarVLeeVHLThe characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layersPharm Res20042164164815139521
   PubMed Web of Science ®Google Scholar
• KohaneDSTseJYYeoYPaderaRShubinaMLangerRBiodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneumJ Biomed Mater Res200677A351361
   Web of Science ®Google Scholar
• WangGLiuSJUengSWChanECThe release of cefazolin and gentamicin from biodegradable PLA/PGA beadsInt J Pharm200427320321215010144
   PubMed Web of Science ®Google Scholar
• XiaoRZZengZWZhouGLWangJJLiFZWangAMRecent advances in PEG-PLA block copolymer nanoparticlesInt J Nanomedicine201051057106521170353
   PubMed Web of Science ®Google Scholar
• LorenzSHauserCPAutenriethBWeissCKLandfesterKMailanderVThe softer and more hydrophobic the better: influence of the side chain of polymethacrylate nanoparticles for cellular uptakeMacromol Biosci2010101034104220572275
   PubMed Web of Science ®Google Scholar
• SajeeshSSharmaCPCyclodextrin-insulin complex encapsulated in polymethacrylic acid based nanoparticles for oral insulin deliveryInt J Pharm200632514715416859846
   PubMed Web of Science ®Google Scholar
• JoralemonMJMcRaeSEmrickTPEGylated polymers for medicine: from conjugation to self-assembled systemsChem Comm2010461377139320162127
   PubMed Web of Science ®Google Scholar
• VlerkenLEVyasTKAmijiMMPoly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular deliveryPharm Res2007241405141517393074
   PubMed Web of Science ®Google Scholar
• PanosIAcostaNHerasANew drug delivery systems based on chitosanCurr Drug Discov Technol2008533334119075614
   PubMedGoogle Scholar
• ParkJHSaravanakumarGKimKKwonICTargeted delivery of low molecular drugs using chitosan and its derivativesAdv Drug Deliv Rev200962284119874862
   PubMed Web of Science ®Google Scholar
• KumariAYadavSKYadavSCBiodegradable polymers nanoparticles based drug delivery systemsColloids Surf B Biointerfaces20107511819782542
   PubMed Web of Science ®Google Scholar
• SaraogiGKGuptaPGuptaUDJainNKAgrawalGPGelatin nanocarriers as potential vectors for effective management of tuberculosisInt J Pharm200938514314919819315
   PubMed Web of Science ®Google Scholar
• HamidiMAzadiARafieiPHydrogel nanoparticles in drug deliveryAdv Drug Deliv Rev2008601638164918840488
   PubMed Web of Science ®Google Scholar
• ReisCPNeufeldRJVilelaSRibeiroAJVeigaFReview and current status of emulsions/dispersions technology using an internal gelation process for the design of alginate particlesJ Microencapsul20062324525716801237
   PubMed Web of Science ®Google Scholar
• SchiffelersRStormGBakker-WoudenbergILiposome-encapsulated aminoglycosides in pre-clinical and clinical studiesJ Antimicrob Chemother20014833333411532996
   PubMed Web of Science ®Google Scholar
• JungSKLimDHJungSHLeeJEJeongKSSeongHAmphotercin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristicsEur J Pharm Sci20093731332019491021
   PubMed Web of Science ®Google Scholar
• HuynhNTPassiraniCSaulnierPBenoitJPLipid nanocapsules: a new platform for nanomedicineInt J Pharm200937920120919409468
   PubMed Web of Science ®Google Scholar
• PissuwanDCortieCHBalenzuelaSMCortieMBFunctionalized gold nanoparticles for controlling pathogenic bacteriaTrends Biotechnol20102820721320071044
   PubMed Web of Science ®Google Scholar
• SeleemMNMunusamyPRanjanAAlqublanHPickrellGSriragnanathanNSilica-antibiotic hybrid nanoparticles for targeting intracellular pathogensAntimicrob Agents Chemother2009534270427419667284
   PubMed Web of Science ®Google Scholar
• Izquierdo-BarbaIVallet-RegiMKupferschmidtNTerasakiOSchmidtchenAMalmstenMIncorporation of antimicrobial compounds in mesoporous silica film monolithBiomaterials2009305729573619628277
   PubMed Web of Science ®Google Scholar
• RosenholmJMPeuhuEErikssonJESahlgrenCLindenMTargeted intracellular delivery of hydrophobic agents using mesoporous hybrid silica nanoparticles as carrier systemsNano Lett200993308331119736973
   PubMed Web of Science ®Google Scholar
• WanXWangDLiuSFluorescent pH-sensing organic/inorganic hybrid mesoporous silica nanoparticles with tunable redox-responsive release capacityLangmuir201026155741557920839827
   PubMed Web of Science ®Google Scholar
• VasirJKLabhasetwarVBiodegradable nanoparticles for cytosolic delivery of therapeuticsAdv Drug Deliv Rev20075971872817683826
   PubMed Web of Science ®Google Scholar
• DavdaJLabhasetwarVCharacterization of nanoparticle uptake by endothelial cellsInt J Pharm2002233515911897410
   PubMed Web of Science ®Google Scholar
• FerratiSMackAChiappiniCLiuXBeanAJFerrariMIntracellular trafficking of silicon particles and logic-embedded vectorsNanoscale201021512152020820744
   PubMed Web of Science ®Google Scholar
• MartinsMViveirosMCoutoIAmaralLTargeting human macrophages for enhanced killing of intracellular XDR-TB and MDR-TBInt J Tuberc Lung Dis20091356957319383188
   PubMed Web of Science ®Google Scholar
• LecarozCBlanco-PrietoMJBurrellMAGamazoCIntracellular killing of Brucella melitensis in human macrophages with microsphere encapsulated gentamicinJ Antimicrob Chemother20065854955616799160
   PubMed Web of Science ®Google Scholar
• KamatMEl-BoubbouKZhuDCLansdellTLuXLiWHyaluronic acid immobilized magnetic nanoparticles for active targeting and imaging of macrophagesBioconj Chem20102121282135
   PubMed Web of Science ®Google Scholar
• LeeHFongeHJoangBReillyRMAllenCThe effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticlesMol Pharm201071195120820476759
   PubMed Web of Science ®Google Scholar
• PassarellaRJSprattDEvan der EndeAEPhillipsJGWuHSathiyakumarVTargeted nanoparticles that deliver a sustained, specific release of paclitaxel to irradiated tumorsCancer Res2010704550455920484031
   PubMed Web of Science ®Google Scholar
• RuoslahtiEBhatiaSNSailorMGTargeting of drugs and nanoparticles to tumorsJ Cell Biol201018875976920231381
   PubMed Web of Science ®Google Scholar
• VazquezECubasriRUnzuetaURoldanMDomingo-EspanJFerrer-MirallesNInternalization and kinetics of nuclear migration of protein-only, arginine-rich nanoparticlesBiomaterials2010319333933920869766
   PubMed Web of Science ®Google Scholar
• HuCMJKaushalSCaoHSTAryalSSartorMEsenerDHalf-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cellsMol Pharm2010791492020394436
   PubMed Web of Science ®Google Scholar
• YanYJohnstonAPRDoddsAJKamphuisMMJFergusonCPartonRGUptake and intracellular fate of disulfide-bonded polymer hydrogel capsules for doxorubicin delivery to colorectal cancer cellsACS Nano201042928293620420377
   PubMed Web of Science ®Google Scholar
• WangMThanouMTargeting nanoparticles to cancerPharmacol Res201062909920380880
   PubMed Web of Science ®Google Scholar
• NobsLBucheggerFGurnyRAllemannECurrent methods for attaching targeting ligands to liposomes and nanoparticlesJ Pharm Sci20079019801992
   Google Scholar
• GuFZhangLTeplyBAMannNWangARadovic-MorenoAFPrecise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymersProc Natl Acad Sci U S A20081052586259118272481
   PubMed Web of Science ®Google Scholar
• MurthyNCampbellJFaustoNHoffmannASStaytonPSBio- inspired pH-responsive polymers for the intracellular delivery of biomolecular drugsBioconj Chem200314412419
   PubMed Web of Science ®Google Scholar
• MkandawireMPohlAGubarevichTLapinaVApplehansDRodelGSelective targeting of green fluorescent nanodiamond conjugates to mitochondria in HeLa cellsJ Biophotonics2009259660619504515
   PubMed Web of Science ®Google Scholar
• MisraRSahooSKIntracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapyEur J Pharm Sci20103915216319961929
   PubMed Web of Science ®Google Scholar
• BallandOPinto-AlphandarHVironAPuvionEAndremontACouvreurPIntracellular distribution of ampicillin in murine macrophages infected with Salmonella typhimurium and treated with (3H) ampicillin-loaded nanoparticlesJ Antimicrob Chemother1996371051158647751
   PubMed Web of Science ®Google Scholar
• StavruFBouillaudFSartoriARicquierDCossartPListeria monocytogenes transiently alters mitochondrial dynamics during infectionProc Natl Acad Sci U S A20111083612361721321208
   PubMed Web of Science ®Google Scholar
• ZhangLGuFXChanJMWangAZLangerRSFarokhzadOCNanoparticles in medicine: therapeutic applications and developmentsClin Pharmacol Ther20088376176917957183
   PubMed Web of Science ®Google Scholar
• LamprechtAUbrichNYamamotoHSchaferUTakeuchiHMaincentPBiodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel diseaseJ Pharmacol Exp Ther200129977578111602694
   PubMed Web of Science ®Google Scholar
• LecarozCGamazoCRenedoMJBlanco-PrietoMJBiodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicinJ Microencapsul20062378279217123922
   PubMed Web of Science ®Google Scholar
• Blanco-PrietoMJLecarozCRenedoMGKunkovaJGamazoCIn vitro evaluation of gentamicin released from microparticlesInt J Pharm200224220320612176247
   PubMed Web of Science ®Google Scholar
• PanyamJLabhasetwarVSustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticlesMol Pharm20041778415832503
   PubMed Web of Science ®Google Scholar
• CloutierMJAntibiotics: mechanisms of action and the acquisition of resistance-when magic bullets lose their magicAm J Pharm Educ199559167172
   Web of Science ®Google Scholar
• WangHXuKLiuLTanJPKChenYLiYThe efficacy of self-assembled cationic antimicrobial peptides nanoparticles against Cryptococcus neoformans for the treatment of meningitisBiomaterial20103128742881
   PubMed Web of Science ®Google Scholar
• BuckiRLeszczynskaKNamiotASolokowskiWCalthelicidin LL-37: a multitask antimicrobial peptideArch Immunol Ther Exp2010851525
   Web of Science ®Google Scholar
• EbyDMFarringtonKEJohnsonGRSynthesis of bioinorganic antimicrobial peptide nanoparticles with potential therapeutic propertiesBiomacromolecules2008924812494
   Web of Science ®Google Scholar
• LiuLXuKWangHTanJPKFanWVenkatramanSSSelf- assembled cationic peptide nanoparticles as an efficient antimicrobial agentNat Nanotechnol2009445746319581900
   PubMed Web of Science ®Google Scholar
• ChoWMJoshiBPChoHLeeKHDesign and synthesis of novel antibacterial peptide-resin conjugatesACS Med Chem Lett20071757725776
   Web of Science ®Google Scholar
• DurrUHNSudheendraUSRamamoorthyALL-37, the only human member of the cathelicidin family of antimicrobial peptidesBiochim Biophys Acta200617581408142516716248
   PubMed Web of Science ®Google Scholar
• LeszczynskaKNamiotAHanmeyPABuckiRModulation of exogenous antibiotic activity by host cathelicidin LL-37APIMS2010118830836
   Web of Science ®Google Scholar
• FonsecaSBPereiraMPKelleySORecent advances in the use of cell-penetrating peptides for medical and biological applicationsAdv Drug Deliv Rev20096195396419538995
   PubMed Web of Science ®Google Scholar
• JulianoRLAlamRDixitVKangHMCell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agentsWiley Interdiscip Rev Nanomed Nanobiotechnol20091332433520049800
   PubMed Web of Science ®Google Scholar
• SchmidtNMishraALaiGHWongGCLArginine-rich cell-penetrating peptidesFEBS Lett20105841806181319925791
   PubMed Web of Science ®Google Scholar
• MurdayJSSiegelRWSteinJWrightJFTranslational nanomedicine: status assessment and opportunitiesNanomedicine NBM20095251273
   PubMed Web of Science ®Google Scholar
• AllhoffFThe coming era of nanomedicineAm J Bioeth200991031119998074
   PubMed Web of Science ®Google Scholar